VitaNova Life Sciences Corporation Cost of Revenue
VitaNova Life Sciences Corporation (VNOV) reported Cost of Revenue of $291.06 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-09-14
- VitaNova Life Sciences Corporation cost of revenue for the quarter ending 2026-07-31 was $291.06K, a 728.79% increase year-over-year.
- VitaNova Life Sciences Corporation cost of revenue for the quarter ending 2026-04-30 was $1.52M, a 91.03% increase year-over-year.
- VitaNova Life Sciences Corporation cost of revenue for the quarter ending 2026-01-31 was $393.28K, a 230.47% increase year-over-year.
- VitaNova Life Sciences Corporation cost of revenue for the quarter ending 2025-10-31 was $166.31K, a 22.03% increase year-over-year.
- VitaNova Life Sciences Corporation cost of revenue for fiscal 2026 was $2.11M, a 94.68% increase from fiscal 2025.
- VitaNova Life Sciences Corporation cost of revenue for fiscal 2025 was $1.09M, a 462.95% increase from fiscal 2024.
- VitaNova Life Sciences Corporation cost of revenue for fiscal 2024 was $192.98K.
- VitaNova Life Sciences Corporation cost of revenue for fiscal 2023 was $0.00.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-07-31 | $291.06K 10-Q · filed 2026-09-14 | $1.81M derived: sum of 2 quarters · filed 2026-09-14 | $2.20M derived: sum of 3 quarters · filed 2026-09-14 | $2.37M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $1.91M derived: sum of 2 quarters · filed 2026-07-29 | $2.08M derived: sum of 3 quarters · filed 2026-07-29 | $2.11M 10-K · filed 2026-07-29 |
| 2026-01-31 | $393.28K 10-Q · filed 2026-03-16 | $559.59K derived: sum of 2 quarters · filed 2026-03-16 | $594.71K 10-Q · filed 2026-03-16 | $1.39M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $166.31K 10-Q · filed 2025-12-15 | $201.43K 10-Q · filed 2025-12-15 | $997.23K derived: sum of 3 quarters · filed 2026-09-14 | $1.12M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $35.12K 10-Q · filed 2026-09-14 | $830.92K derived: sum of 2 quarters · filed 2026-09-14 | $949.92K derived: sum of 3 quarters · filed 2026-09-14 | $1.09M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $795.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $914.81K derived: sum of 2 quarters · filed 2026-07-29 | $1.05M derived: sum of 3 quarters · filed 2026-07-29 | $1.09M 10-K · filed 2026-07-29 |
| 2025-01-31 | $119.01K 10-Q · filed 2026-03-16 | $255.29K derived: sum of 2 quarters · filed 2026-03-16 | $290.59K 10-Q · filed 2026-03-16 | $483.58K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-10-31 | $136.28K 10-Q · filed 2025-12-15 | $171.59K 10-Q · filed 2025-12-15 | $364.57K derived: sum of 3 quarters · filed 2025-12-15 | $364.57K derived: sum of 4 quarters · filed 2025-12-15 |
| 2024-07-31 | $35.30K 10-Q · filed 2025-09-12 | $228.29K derived: sum of 2 quarters · filed 2025-09-12 | $228.29K derived: sum of 3 quarters · filed 2025-09-12 | $228.29K derived: sum of 4 quarters · filed 2025-09-12 |
| 2024-04-30 | $192.98K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | $192.98K derived: sum of 2 quarters · filed 2025-07-24 | $192.98K derived: sum of 3 quarters · filed 2025-07-24 | $192.98K 10-K · filed 2025-07-24 |
| 2024-01-31 | $0.00 10-Q · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | $0.00 10-Q · filed 2025-03-17 | |
| 2023-10-31 | $0.00 10-Q · filed 2024-12-13 | $0.00 10-Q · filed 2024-12-13 | ||
| 2023-07-31 | $0.00 10-Q · filed 2024-09-10 | |||
| 2023-04-30 | $0.00 10-K · filed 2024-07-29 | |||
| 2019-04-30 | $0.00 10-K · filed 2019-07-30 | |||
| 2018-04-30 | $0.00 10-K · filed 2019-07-30 |